vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and Massimo Group (MAMO). Click either name above to swap in a different company.
Massimo Group is the larger business by last-quarter revenue ($21.0M vs $10.7M, roughly 2.0× Arbutus Biopharma Corp). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs 9.5%, a 14.0% gap on every dollar of revenue. On growth, Arbutus Biopharma Corp posted the faster year-over-year revenue change (522.2% vs 15.7%). Over the past eight quarters, Arbutus Biopharma Corp's revenue compounded faster (-13.2% CAGR vs -16.5%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
ABUS vs MAMO — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $21.0M |
| Net Profit | $2.5M | $2.0M |
| Gross Margin | — | 41.5% |
| Operating Margin | 13.9% | 13.1% |
| Net Margin | 23.5% | 9.5% |
| Revenue YoY | 522.2% | 15.7% |
| Net Profit YoY | 112.7% | 215.0% |
| EPS (diluted) | $0.01 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $21.0M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | $10.7M | $18.9M | ||
| Q1 25 | — | $14.9M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | — | $25.6M | ||
| Q2 24 | — | $35.4M | ||
| Q1 24 | — | $30.2M |
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $1.5M | ||
| Q2 25 | $2.5M | $77.7K | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-2.5M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | — | $3.2M |
| Q4 25 | — | 41.5% | ||
| Q3 25 | — | 42.0% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 28.4% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 27.2% | ||
| Q2 24 | — | 32.5% | ||
| Q1 24 | — | 34.7% |
| Q4 25 | — | 13.1% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | 13.9% | 0.8% | ||
| Q1 25 | — | -18.2% | ||
| Q4 24 | — | -15.4% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 13.2% |
| Q4 25 | — | 9.5% | ||
| Q3 25 | — | 9.0% | ||
| Q2 25 | 23.5% | 0.4% | ||
| Q1 25 | — | -14.0% | ||
| Q4 24 | — | -9.5% | ||
| Q3 24 | — | -9.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 10.6% |
| Q4 25 | — | $0.05 | ||
| Q3 25 | — | $0.04 | ||
| Q2 25 | $0.01 | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $5.8M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $83.0M | $23.7M |
| Total Assets | $103.3M | $51.4M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.8M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | $37.4M | — | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $23.7M | ||
| Q3 25 | — | $21.7M | ||
| Q2 25 | $83.0M | $20.2M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | — | $22.5M | ||
| Q2 24 | — | $24.7M | ||
| Q1 24 | — | $18.1M |
| Q4 25 | — | $51.4M | ||
| Q3 25 | — | $44.4M | ||
| Q2 25 | $103.3M | $45.9M | ||
| Q1 25 | — | $46.4M | ||
| Q4 24 | — | $54.9M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | — | $49.9M | ||
| Q1 24 | — | $47.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $4.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -6.24× | 2.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.0M | ||
| Q3 25 | — | $633.2K | ||
| Q2 25 | $-15.7M | $-1.4M | ||
| Q1 25 | — | $-3.3M | ||
| Q4 24 | — | $9.1M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | — | $-6.5M | ||
| Q1 24 | — | $-637.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $-6.7M | ||
| Q1 24 | — | $-741.4K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 49.7% | ||
| Q3 24 | — | 18.1% | ||
| Q2 24 | — | -19.0% | ||
| Q1 24 | — | -2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 2.01× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | -6.24× | -17.92× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.30× | ||
| Q1 24 | — | -0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
